Anixa Biosciences, Inc. ANIX
Set alert
2.99 USD -0.13 -4.17%
At close
3.10 +0.11 +3.68%
Pre-market · Nov 3, 4:00 AM ET
2.99 Day range 3.15
2.32 52-week range 5.46
- YTD
- -4.17%
- 1 year
- -27.78%
- Open
- 3.14
- Prev close
- 3.12
- Mkt cap
- 103.94M
- Vol
- 128.34K
- Avg vol
- 278.49K
- EPS
- -0.32
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.99
- High
- 3.15
- Forward P/E
- -7.17
- Beta
- 0.85
- Short ratio
- 3.03
- Inst. own
- 17.46%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 21, 2025
- 50-d avg
- 3.17
- 200-d avg
- 3.04
- 1y target
- 8.50
MAX chart
Signals (75)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Jul 1, 2026 | 4 months ago |
| SMA: Bearish | Jan 1, 2026 | 10 months ago |
| SMA: Bullish | Apr 1, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 1, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 1, 2024 | 2 years ago |
| SMA: Bearish | Jan 1, 2024 | 2 years ago |
| SMA: Bearish | Jan 1, 2024 | 2 years ago |
| SMA: Bullish | Oct 1, 2023 | 3 years ago |
| SMA: Bullish | Oct 1, 2023 | 3 years ago |
| SMA: Bearish | Apr 1, 2023 | 3 years ago |
| SMA: Bearish | Apr 1, 2023 | 3 years ago |
| SMA: Bullish | Jul 1, 2022 | 4 years ago |
| SMA: Bullish | Jul 1, 2022 | 4 years ago |
| SMA: Bearish | Oct 1, 2021 | 5 years ago |
| SMA: Bearish | Oct 1, 2021 | 5 years ago |
| SMA: Bullish | Jan 1, 2021 | 5 years ago |
| SMA: Bullish | Jan 1, 2021 | 5 years ago |
| SMA: Bearish | Oct 1, 2019 | 7 years ago |
| SMA: Bearish | Apr 1, 2019 | 7 years ago |
| SMA: Bullish | Jan 1, 2019 | 7 years ago |
Newest 20 of 75.
Financial health
Altman Z-Score
7.94 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -12.1×
FY 2016 5y median -11.3× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 8.8×
FY 2016 5y median 5.6× FY 2025
P/FCF -18.7×
FY 2016 5y median -18.7× FY 2025
EV/EBITDA -12.1×
FY 2016 5y median -9.8× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -5.4%
FY 2016 5y median -5.4% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -72.1%
FY 2016 5y median -46.8% FY 2025
ROIC -82.7%
FY 2016 5y median -48.8% FY 2025
ROA -68.0%
FY 2016 5y median -44.7% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 15.4%
FY 2016 FY 2025
EPS (diluted) 12.8%
FY 2016 FY 2025
Free Cash Flow 2.2%
FY 2016 FY 2025
Financial Health
Current Ratio 8.1×
FY 2016 5y median 12.5× FY 2025
Quick Ratio 8.1×
FY 2016 5y median 12.5× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-10-31
